Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
In silico 		Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
In silico 		Emergency use authorization Experimental Antiviral Jan/23/2023
T cells
In silico 		Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Remdesivir
In silico 		Approved by FDA Experimental Antiviral Jan/18/2023
Sotrovimab
In silico 		Emergency use authorization Experimental Antiviral Jul/14/2022
Bamlanivimab
In silico 		Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
In silico 		Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
S309
In silico 		Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022
BNT162b2
In silico 		Approved by FDA Experimental Vaccine Jun/22/2022
Cilgavimab
In silico 		Emergency use authorization Experimental Antiviral Jun/18/2022
Tixagevimab
In silico 		Emergency use authorization Experimental Antiviral Jun/18/2022
Bebtelovimab
In silico 		Emergency use authorization Experimental Antiviral Jun/18/2022
REGEN-COV
In silico 		Emergency use authorization Experimental Antiviral Jun/03/2022
Ivermectin
In silico 		Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baricitinib
In silico 		Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Colchicine
In silico 		Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022
Camptothecin
In silico 		Potential treatment - theoretical effect Natural product Antiviral Jan/31/2022
PF-00835231
In silico 		Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
Dexamethasone
In silico 		Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
S2N12
In silico 		Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Export (.csv)